Search

Your search keyword '"Aversa C"' showing total 200 results

Search Constraints

Start Over You searched for: Author "Aversa C" Remove constraint Author: "Aversa C"
200 results on '"Aversa C"'

Search Results

1. Clinical utility of exemestane in the treatment of breast cancer&nbsp

16. 1645P Tumour suppressor gene signature predicts early progression in metastatic hormone-sensitive metastatic prostate cancer (mHSPC) patients

17. Progress in design and processing of polyhydroxyalkanoates (PHAs): Home compostable poly(3‐hydroxybutyrate‐co—3‐hydroxyhexanoate) (PHBHHx)/polybutylene succinate‐co‐adipate (PBSA) blend.

18. Electrochemotherapy as palliative treatment in patients with recurrent and/or metastatic head and neck tumours: features analysis for an early determination of the partial responsive patients

20. 1868P Real-world safety of the 6-weekly pembrolizumab regimen in cancer patients treated in South East London

21. 625P TMPRSS2-ERG expression and clinical evolution of metastatic hormone sensitive prostate cancer

23. 1791P Molecular profiling and prognostic relevance of low PTEN expression in metastatic hormone-sensitive prostate cancer patients

24. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

29. Advance on processing of compostable and thermally stable biodegradable polyester blends.

30. Cast extrusion of low gas permeability bioplastic sheets in PLA/PBS and PLA/PHB binary blends.

34. Effect of micro-lamellar talc on dimensional accuracy and stability in injection molding of PLA/PBSA blends.

38. Mielolipoma gigante del surrene: case report e review della letteratura

42. 583 Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study

49. The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients

50. Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction.

Catalog

Books, media, physical & digital resources